Ewa K.
- Country
- Poland
- Department
- Private Practice
Research Overview
- Efficacy and Safety of MET097 in Adults with Overweight or Obesity: A Phase 3, Randomized, Placebo-Controlled Trial
- Phase 3 Randomized, Placebo‑Controlled Trial Assessing Efficacy and Safety of MET097, a Long‑Acting GLP‑1 Receptor Agonist, in Overweight/Obese Adults with Type 2 Diabetes
- Long-Term Safety and Efficacy Evaluation of ARO-APOC3 in Adults with Mixed Dyslipidemia: A Phase 2 Open-Label Extension Study
Data & Insights
Has run more than one trial at 188 of 586 partner sites.
Specializations
Metabolic Disorders
Specializes in investigating therapeutic approaches for Type 2 Diabetes Mellitus and its complications, with particular focus on evaluating glycemic control treatments and novel therapeutic agents.
- Diabetic Peripheral Neuropathy
- Chronic Pain Management in Diabetes
- Glycemic Control Interventions
The investigator works with innovative treatments addressing both primary diabetic conditions and associated complications.
Cardiovascular Health
Focuses on cardiovascular disease prevention and treatment, with expertise in managing atrial fibrillation and various forms of dyslipidemia.
- Mixed Dyslipidemia
- Hypertriglyceridemia
- Atherosclerotic Cardiovascular Disease
Evaluates cardioembolic event prevention and cardiovascular safety in various patient populations.
Metabolic-Cardiovascular Interface
Investigates the intersection between metabolic conditions and cardiovascular health, with particular attention to obesity-related cardiovascular complications.
- Obesity Management
- Cardiovascular Risk Assessment
- Preventive Cardiology
Conducts research on therapeutic interventions targeting both metabolic and cardiovascular outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.